Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children

Autor: Otto Laub, Georg Leipold, Antoaneta A. Toncheva, David Peterhoff, Sebastian Einhauser, Patrick Neckermann, Natascha Borchers, Elisangela Santos-Valente, Parastoo Kheiroddin, Heike Buntrock-Döpke, Sarah Laub, Patricia Schöberl, Andrea Schweiger-Kabesch, Dominik Ewald, Michael Horn, Jakob Niggel, Andreas Ambrosch, Klaus Überla, Stephan Gerling, Susanne Brandstetter, Ralf Wagner, Michael Kabesch, Corona Virus Antibodies in Children from Bavaria (CoKiBa) Study Group, Bettina Aichholzer, Georg Mair, Michaela Wruk, Imke Reischl, David Antos, Stephan von Koskull, Christian Becker, Elisabeth Beer, Hubert Schirmer, Georg Birkinger, Andreas Blueml, Mona Castrop, Jost Dieckerhoff, Renate Eichhorn, Gudrun Fleck, Alfred Heihoff, Jürgen Geuder, Jens Grombach, Peter Gutdeutsch, Florian Segerer, Thomas Habash, Sonja Habash, Susanne Harner, Christoph Herbst, Daniela Heuschmann, Meike Hofmann, Birgit Jork-Kaeferlein, Monika Schwarz, Reinhard Hopfner, Guido Judex, Bastian Baumgartner, Monika Corbacioglu, Sabrina Lindner, Bettina Meinel, Alena Bauer, Hannes Löw, Annamaria Szulagyi-Kovacs, Annegret Klein, Cosima Koering, Niclas Landvogt, Claudia Soehngen, Karin Rasp, Gudrun Schick-Niedermeier, Marinus Laub, Petra Schmid-Seibold, Johannes Pawlak, Michaela Reitz, Georg Puchner, Christiane Razeghi, Stefan Razeghi, Christine Rehe, Klaus Rehe, Matthias Scheffel, Ludwig Kaesbauer, Roland Schmid, Michael Strobelt, Nina Schoetzau, Marko Senjor, Michael Sperlich, Guenter Theuerer, Guenter Steidle, German Tretter, Victor von Arnim, Marlene Volz-Fleckenstein

Publikováno v: Frontiers in Pediatrics, Vol 9 (2021)

Background: Children and youth are affected rather mildly in the acute phase of COVID-19 and thus, SARS-CoV-2 infection infection may easily be overlooked. In the light of current discussions on the vaccinations of children it seems necessary to bett

Externí odkaz: https://doaj.org/article/ffa1810b2ffd492d8e7e8f646a6d105d

Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children.

Autor: Laub O; Pediatric Office Laub, Rosenheim, Germany., Leipold G; Pediatric Office Dr. Leipold, Regensburg, Germany., Toncheva AA; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany., Peterhoff D; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.; Institute of Clinical Microbiology and Hygiene, University Hospital, Regensburg, Germany., Einhauser S; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany., Neckermann P; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany., Borchers N; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany., Santos-Valente E; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany., Kheiroddin P; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany., Buntrock-Döpke H; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.; Member of the Research and Development Campus Regensburg (WECARE) at the Hospital St. Hedwig of the Order of St. John, Regensburg, Germany., Laub S; Pediatric Office Laub, Rosenheim, Germany., Schöberl P; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.; Member of the Research and Development Campus Regensburg (WECARE) at the Hospital St. Hedwig of the Order of St. John, Regensburg, Germany., Schweiger-Kabesch A; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany., Ewald D; Pediatric Office Dr. Heuschmann & Dr. Ewald, Regenstauf, Germany., Horn M; Pediatric Office Dr. Horn, Schönau, Germany., Niggel J; Maganamed Limited, Regensburg, Germany., Ambrosch A; Institute of Laboratory Medicine, Microbiology and Hygiene, Hospital of the Order of St. John, Regensburg, Germany., Überla K; Institute of Clinical and Molecular Virology, FAU Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany., Gerling S; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany., Brandstetter S; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.; Member of the Research and Development Campus Regensburg (WECARE) at the Hospital St. Hedwig of the Order of St. John, Regensburg, Germany., Wagner R; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany.; Institute of Clinical Microbiology and Hygiene, University Hospital, Regensburg, Germany., Kabesch M; University Children's Hospital Regensburg (KUNO) at the Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.; Member of the Research and Development Campus Regensburg (WECARE) at the Hospital St. Hedwig of the Order of St. John, Regensburg, Germany.

Publikováno v: Frontiers in pediatrics [Front Pediatr] 2021 Oct 04; Vol. 9, pp. 678937. Date of Electronic Publication: 2021 Oct 04 (Print Publication: 2021).